期刊
JOURNAL OF MEDICINAL CHEMISTRY
卷 65, 期 10, 页码 7088-7105出版社
AMER CHEMICAL SOC
DOI: 10.1021/acs.jmedchem.2c00335
关键词
-
资金
- JNCASR [DST/SJF/CSA-02/2015-2016, IFCPAR/CEFIPRA-62T10-3]
- Department of Science and Technology (DST) [CRG/2020/004594]
- Science and Engineering Research Board (SERB), New Delhi, India, DST
This article discusses the potential and possibilities of drug repurposing and hybrid drug design in the treatment of AD, presenting several potential drug candidates and discussing their plausible mechanisms of action.
The heterogeneity and complex nature of Alzheimer's disease (AD) isattributed to several genetic risk factors and molecular culprits. The slow pace and increasingfailure rate of conventional drug discovery has led to the exploration of complementarystrategies based on repurposing approved drugs to treat AD. Drug repurposing (DR) is a cost-effective, low-risk, and efficient approach for identifying novel therapeutic candidates for ADtreatment. Similarly, hybrid drug design through the integration of distinct pharmacophoresfrom known or failed drugs and natural products is an interesting strategy to target themultifactorial nature of AD. In this Perspective, we discuss the potential of DR and highlightpromising drug candidates that can be advanced for clinical trials, backed by a detaileddiscussion on their plausible mechanisms of action. Our article fosters research on the hiddenpotential of DR and hybrid drug design with the goal of unravelling new drugs and targets totackle AD
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据